16, Mar 2023
Paxlovid not linked to Covid-19 rebound, FDA says ahead of meeting to consider drug’s full approval

As the US Food and Drug Administration’s independent advisers prepare to discuss Thursday the full approval of Pfizer’s Covid-19 antiviral, Paxlovid, agency experts said this week that clinical trial data shows that it is safe and effective for treatment of mild to moderate illness in high-risk adults.

Leave a Reply

Your email address will not be published. Required fields are marked *


Click one of our representatives below to chat on Telegram or send us an email to tawwasol.com@gmail.com

How can I help you?